More on BCTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (10/22/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BriaCell Therapeutics (NQ:BCTX)
Delayed: 3.60 -0.03 (0.83%)
Prev. Close $3.63  
Open$3.58 
52 Wk High$ 
52 Wk Low$ 
Day High$3.65 
Day Low$3.58 
P/E N/A  
EPS$ 
Volume39,414 

Friends, Peers and Foes (?): BCT, BCTXW, BCTXZ BCTXL (more...)

Sep 8, 2026 07:30 AM BriaCell adds Memorial Sloan Kettering to Phase 3 breast cancer trial
Sep 8, 2026 07:30 AM BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
Aug 24, 2026 07:35 AM BriaCell advances melanoma vaccine candidate to genetic engineering milestone
Jun 26, 2026 04:06 PM Form 8-K BriaCell Therapeutics For: Jun 26
Jun 9, 2026 04:06 PM Form 10-Q BriaCell Therapeutics For: Apr 30
Jun 3, 2026 06:04 AM Form 8-K BriaCell Therapeutics For: May 31
Jun 2, 2026 08:01 AM Form 424B5 BriaCell Therapeutics
May 31, 2026 07:59 PM BriaCell Therapeutics Announces Pricing of Offering
May 15, 2026 07:31 AM BriaCell develops ovarian cancer immunotherapy candidate
May 15, 2026 07:30 AM BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
View All Articles

Entities mentioned with BCTX

View All Entities